Murine infection model for contagious equine metritis: a new venereal disease of horses.

The research discusses the development of a murine infection model to study contagious equine metritis, a venereal disease in horses, caused by a bacterium called Haemophilus equigenitalis. The study also explores the effectiveness of immunization and observed differences in the bacterium’s behavior in both the lab and animal environment.

Development of the Infection Model

• The researchers established a novel mouse model to investigate contagious equine metritis, a sexually transmitted disease in horses which is primarily caused by the bacterium Haemophilus equigenitalis.
• The model involved the subcutaneous implantation of small porous chambers in mice, which were then inoculated with the bacteria after 1 to 3 weeks.
• The study successfully established infections that persisted for over 30 days, either by direct transfer of infective chamber fluid or injection of bacteria cultivated in a laboratory.

Immunization Investigation

• The study further investigated the concept of immunization of these mice.
• The mice were immunized with formaldehyde-treated cells of the bacteria, intended to provoke a defensive response from the immune system without causing illness.
• This procedure led to a significant degree of strain-related immunity to the infection amongst the mice.
• Interestlginly, protection did not appear to demand the involvement of complement, a part of the immune system generally engaged in protection against bacterial infections.

Observation of Bacterial Behaviour

• Through this research, noticeable variances in staining characteristics and cell morphology were found between bacteria grown within the mouse chambers and those developed within a laboratory medium.
• These dissimilarities appeared more evidently in bacterial smears stained by a modified Gimenez method compared to those stained by the generally-used Gram stain.

Significance and Applications

• The development of this murine model may pave the way for more convenient and cost-effective research into the immunobiological behaviour of this bacterium.
• This can also lead to potential advancements in the development of suitable vaccines or therapeutics against this sexually transmitted disease in horses.